Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Adjuvant S-1 Plus Oxaliplatin in Resected Stage III Gastric Cancer
jRCT2080222076Phase 2
- Sponsor
- Yakult Honsha
- Start
- May 2013
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur and oxaliplatin in gastric cancer (GC), sponsored by Yakult Honsha.
02
Drugs
tegafuroxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT2080222076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222076.